Encompass Health (NYSE:EHC) Updates FY 2025 Earnings Guidance

Encompass Health (NYSE:EHC) issued an update on its FY 2025 earnings guidance on Thursday morning. The company provided earnings per share guidance of 4.670-4.960 for the period, compared to the consensus earnings per share estimate of 4.770. The company issued revenue guidance of $5.8 billion-$5.9 billion, compared to the consensus revenue estimate of $5.8 billion.

Analysts Set New Price Targets

Several analysts recently commented on EHC shares. Royal Bank of Canada boosted their price target on Encompass Health from $105.00 to $110.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 30th. KeyCorp increased their target price on shares of Encompass Health from $115.00 to $117.00 and gave the company an “overweight” rating in a research report on Tuesday, October 29th. Truist Financial restated a “buy” rating and set a $116.00 price target (up from $108.00) on shares of Encompass Health in a research report on Wednesday, October 30th. Finally, Barclays raised their target price on shares of Encompass Health from $109.00 to $116.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 29th. Nine research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat.com, Encompass Health currently has an average rating of “Buy” and an average price target of $107.11.

Encompass Health Trading Down 3.7 %

EHC traded down $3.79 during trading hours on Thursday, reaching $98.41. The company’s stock had a trading volume of 1,096,305 shares, compared to its average volume of 643,975. The stock has a market cap of $9.91 billion, a PE ratio of 23.77, a P/E/G ratio of 1.18 and a beta of 0.90. Encompass Health has a fifty-two week low of $71.99 and a fifty-two week high of $104.55. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 1.04. The business’s 50-day moving average is $96.43 and its 200-day moving average is $95.08.

Encompass Health (NYSE:EHC) last issued its quarterly earnings data on Thursday, February 6th. The company reported $1.17 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.05 by $0.12. Encompass Health had a return on equity of 17.60% and a net margin of 8.10%. As a group, equities research analysts predict that Encompass Health will post 4.29 earnings per share for the current fiscal year.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.